Phaarmasia Limited
₹89.00₹0.00 (0.0%)
Phaarmasia Limited’s quoted price sits in the upper half of its reported 52-week range, 32.45% below the high.
BSE · ZENITHHE.BO · INR
Stock price, earnings
Quote as of Oct 30, 2026, 06:48 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Zenith Healthcare Limited’s quoted price sits in the upper half of its reported 52-week range, 10.19% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Zenith Healthcare Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Zenith Healthcare Ltd. is a pharmaceutical company that specializes in producing a variety of drug formulations, encompassing tablets, capsules, oral suspensions, and injectable solutions. Its comprehensive product portfolio extends across a wide array of therapeutic areas, such as antibiotics and anti-infectives, as well as treatments targeting the cardiovascular, central nervous, gastrointestinal, musculoskeletal, respiratory, and genitourinary systems. Additionally, the company offers nutritional products, dermatological solutions, and medications for the endocrine system. Mahendra C. Raycha founded the enterprise on November 15, 1994, and its main operations are based in Ahmedabad, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:19 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹89.00₹0.00 (0.0%)
Phaarmasia Limited’s quoted price sits in the upper half of its reported 52-week range, 32.45% below the high.
₹73.30-₹0.50 (-0.68%)
Ishita Drugs and Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 19.32% below the high.
₹130.85₹0.00 (0.0%)
Chemo Pharma Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 13.91% below the high.
₹25.00-₹1.18 (-4.51%)
Zenlabs Ethica Limited’s quoted price sits in the lower half of its reported 52-week range, 37.48% below the high.
₹5.35-₹0.01 (-0.19%)
Add-Shop E-Retail Limited’s quoted price sits in the lower half of its reported 52-week range, 46.45% below the high.
₹14.05-₹0.57 (-3.9%)
Norris Medicines Limited’s quoted price sits in the lower half of its reported 52-week range, 29.96% below the high.
₹5.01₹0.00 (0.0%)
Cian Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 34.6% below the high.
₹26.90₹0.00 (0.0%)
Desh Rakshak Aushdhalaya Ltd.’s quoted price sits in the lower half of its reported 52-week range, 47.34% below the high.